Recent 8-K filings for TELA

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 20:11 UTC earnings item 2.02item 7.01item 9.01

  TELA Bio Q1 revenue $19.1M (+3% YoY); net loss $12.3M; reiterates FY2026 revenue growth at least 8%

source · TELA on sec.gov